![Svafa Grönfeldt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Svafa Grönfeldt
Direttore/Membro del Consiglio presso EMBLA MEDICAL HF.
Patrimonio netto: 86 125 $ in data 31/05/2024
Profilo
Svafa Grönfeldt is the founder of The MET Fund LLC.
She currently holds the following positions: Vice Chairman at Össur hf since 2008, Director at Marel hf since 2021, Director at Icelandair Group hf since 2019, and Professor at Massachusetts Institute of Technology since 2016.
She previously held positions as Deputy Chief Executive Officer at Actavis Group hf from 2002 to 2007, Director at Landsbankinn hf, Director at Origo hf from 2019 to 2021, Director at Alvogen, Inc. from 2010 to 2011, Managing Partner at Deloitte & Touche LLP, Assistant Professor at the University of Iceland, Member-Supervisory Board at Lotus Pharmaceutical Co., Ltd., and President at Reykjavik University from 2007 to 2010.
Dr. Grönfeldt's education includes a graduate degree from Florida Institute of Technology, Inc. and a doctorate degree from London School of Economics & Political Science.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ICELANDAIR GROUP HF
0.03% | 31/12/2023 | 12 500 000 ( 0.03% ) | 86 125 $ | 31/05/2024 |
Posizioni attive di Svafa Grönfeldt
Società | Posizione | Inizio |
---|---|---|
EMBLA MEDICAL HF. | Direttore/Membro del Consiglio | 01/02/2008 |
ICELANDAIR GROUP HF. | Direttore/Membro del Consiglio | 08/03/2019 |
MAREL HF. | Direttore/Membro del Consiglio | 01/03/2021 |
The MET Fund LLC
![]() The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Fondatore | - |
Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/2021 |
Precedenti posizioni note di Svafa Grönfeldt
Società | Posizione | Fine |
---|---|---|
ORIGO HF. | Direttore/Membro del Consiglio | 01/01/2021 |
Reykjavik University | Presidente | 01/01/2010 |
Actavis Group hf
![]() Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Corporate Officer/Principal | 01/01/2007 |
LOTUS PHARMACEUTICAL CO., LTD. | Direttore/Membro del Consiglio | - |
░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Svafa Grönfeldt
Florida Institute of Technology, Inc. | Graduate Degree |
London School of Economics & Political Science | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
EMBLA MEDICAL HF. | Health Technology |
LOTUS PHARMACEUTICAL CO., LTD. | Health Technology |
ICELANDAIR GROUP HF. | Transportation |
ORIGO HF. | Distribution Services |
MAREL HF. | Producer Manufacturing |
Aziende private | 5 |
---|---|
Landsbankinn hf
![]() Landsbankinn hf Major BanksFinance Landsbankinn hf engages in the provision of banking and financial services. It operates through the following segments: Personal Banking, Corporate Banking, Markets, Treasury, and Support Functions. The Personal Banking segment provides financial services through the bank’s branch network to individuals and to small and medium-size businesses. The Corporate Banking offers financial services to corporate clients and to small and medium-size businesses. The Markets segment includes brokerage services in securities, foreign currencies and derivatives, securities offerings, and advisory services. The Treasury segment incorporates the bank’s funding and liquidity management, market making in money markets, and determines the bank’s internal pricing. The Support Functions segment consists of finance (excluding treasury), risk management, and information technology; as well as the chief executive officer's office which comprises of human resources, marketing and communications, and compliance. The company was founded in 1886 and is headquartered in Reykjavik, Iceland. | Finance |
Alvogen, Inc.
![]() Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
The MET Fund LLC
![]() The MET Fund LLC Investment ManagersFinance The MET Fund LLC (MET Fund) is a venture capital firm founded in 2019 by Norbert Chang and Svafa Grönfeldt. The firm is headquartered in Boston. | Finance |
Actavis Group hf
![]() Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
- Borsa valori
- Insiders
- Svafa Grönfeldt